BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26666459)

  • 21. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia.
    Forsblom E; Ruotsalainen E; Ollgren J; Järvinen A
    Clin Infect Dis; 2013 Feb; 56(4):527-35. PubMed ID: 23087397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
    Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
    Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automatic notification and infectious diseases consultation for patients with Staphylococcus aureus bacteremia.
    Djelic L; Andany N; Craig J; Daneman N; Simor A; Leis JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):282-283. PubMed ID: 29699836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proactive infectious disease consultation at the time of blood culture collection is associated with decreased mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study.
    Kawasuji H; Sakamaki I; Kawamura T; Ueno A; Miyajima Y; Matsumoto K; Kawago K; Higashi Y; Yamamoto Y
    J Infect Chemother; 2020 Jun; 26(6):588-595. PubMed ID: 32085966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease.
    Kang CK; Kwak YG; Park Y; Song KH; Kim ES; Jung SI; Park KH; Park WB; Kim NJ; Kim YK; Jang HC; Lee S; Jeon JH; Kwon KT; Kim CJ; Kim YS; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1119-1123. PubMed ID: 29667110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation Among Infectious Diseases Pharmacists for the Treatment of
    White BP; Barber KE; Chastain DB
    J Pharm Pract; 2023 Apr; 36(2):295-302. PubMed ID: 34399064
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
    Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.
    Tissot F; Calandra T; Prod'hom G; Taffe P; Zanetti G; Greub G; Senn L
    J Infect; 2014 Sep; 69(3):226-34. PubMed ID: 24844825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital.
    Borde JP; Batin N; Rieg S; Feik R; Reimling C; Kern WV; de With K; Hübner J; Ruhnke M; Kaier K
    Infection; 2014 Aug; 42(4):713-9. PubMed ID: 24889541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
    Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
    J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of an infectious diseases consultation service on the quality of care and the survival of patients with infectious diseases].
    Rieg S; Küpper MF
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(7):500-10. PubMed ID: 26593765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of infectious diseases consultation for children with Staphylococcus aureus bacteremia.
    Whittington KJ; Ma Y; Butler AM; Hogan PG; Ahmed F; Flowers J; Milburn G; Morelli JJ; Newland JG; Fritz SA
    Pediatr Res; 2022 Dec; 92(6):1598-1605. PubMed ID: 35982140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
    Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
    Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study.
    Nguyen CT; Gandhi T; Chenoweth C; Lassiter J; Dela Pena J; Eschenauer G; Nagel JL
    J Antimicrob Chemother; 2015 Dec; 70(12):3390-6. PubMed ID: 26338049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study.
    Verhagen DW; van der Meer JT; Hamming T; de Jong MD; Speelman P
    Scand J Infect Dis; 2003; 35(8):459-63. PubMed ID: 14514144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
    Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
    J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.